Results 271 to 280 of about 9,057,553 (322)
Some of the next articles are maybe not open access.
JAMA: The Journal of the American Medical Association, 1969
To the Editor:— The following is a case report of Fabry's disease. The report is submitted for the purpose of aiding in establishing the incidence of the malady. The disease is becoming recognized with increasing frequency. Report of a case:— This 24-year-old white man relates that he has had a rash about his leg and inguinal areas since early ...
George B. Skipworth, Charles W. Johnson
openaire +3 more sources
To the Editor:— The following is a case report of Fabry's disease. The report is submitted for the purpose of aiding in establishing the incidence of the malady. The disease is becoming recognized with increasing frequency. Report of a case:— This 24-year-old white man relates that he has had a rash about his leg and inguinal areas since early ...
George B. Skipworth, Charles W. Johnson
openaire +3 more sources
Clinical Genetics, 1989
Fifteen hemizygotes and 30 heterozygotes have been diagnosed since our investigations of Fabry's disease were started 10 years ago. They belong mainly to three Danish families. Genetic counseling and prenatal diagnoses have been performed, and in vitro studies of cultured fibroblasts and endothelial cells have been made with special reference to enzyme
Annelise Wandall +2 more
openaire +3 more sources
Fifteen hemizygotes and 30 heterozygotes have been diagnosed since our investigations of Fabry's disease were started 10 years ago. They belong mainly to three Danish families. Genetic counseling and prenatal diagnoses have been performed, and in vitro studies of cultured fibroblasts and endothelial cells have been made with special reference to enzyme
Annelise Wandall +2 more
openaire +3 more sources
The Lancet, 2008
Fabry's disease is an X-linked lysosomal storage disorder caused by abnormalities in the GLA gene, which leads to a deficiency in alpha-galactosidase A. The consequent abnormal accumulation of glycosphingolipids results in several clinical signs and symptoms and substantial morbidity and mortality.
Yuri A. Zarate, Robert J. Hopkin
openaire +2 more sources
Fabry's disease is an X-linked lysosomal storage disorder caused by abnormalities in the GLA gene, which leads to a deficiency in alpha-galactosidase A. The consequent abnormal accumulation of glycosphingolipids results in several clinical signs and symptoms and substantial morbidity and mortality.
Yuri A. Zarate, Robert J. Hopkin
openaire +2 more sources
Clinical Genetics, 2014
Fabry disease (FD) is an X‐linked disease in which mutations of the GLA gene result in a deficiency of the enzyme α‐galactosidase A and subsequent progressive, intralysosomal deposition of undegraded glycosphingolipid products, primarily globotriaosylceramide, in multiple organs.
PISANI, ANTONIO +6 more
openaire +5 more sources
Fabry disease (FD) is an X‐linked disease in which mutations of the GLA gene result in a deficiency of the enzyme α‐galactosidase A and subsequent progressive, intralysosomal deposition of undegraded glycosphingolipid products, primarily globotriaosylceramide, in multiple organs.
PISANI, ANTONIO +6 more
openaire +5 more sources
Current Opinion in Neurology, 2011
This review discusses the literature on Fabry disease mainly in the domain of neurology with special attention to recent advancement.Fabry neuropathy is known as a length-dependent peripheral neuropathy affecting mainly the small myelinated (Aδ) fibers and unmyelinated (C) fibers.
openaire +4 more sources
This review discusses the literature on Fabry disease mainly in the domain of neurology with special attention to recent advancement.Fabry neuropathy is known as a length-dependent peripheral neuropathy affecting mainly the small myelinated (Aδ) fibers and unmyelinated (C) fibers.
openaire +4 more sources
Journal of Echocardiography, 2017
Fabry disease resulting from a deficiency of α-galactosidase A leads to the accumulation of globotriaosylceramide in various organs. Because the disease is an X-linked recessive disorder, males tend to develop more symptoms and more severe symptoms than females.
Toshinori Yuasa +10 more
openaire +2 more sources
Fabry disease resulting from a deficiency of α-galactosidase A leads to the accumulation of globotriaosylceramide in various organs. Because the disease is an X-linked recessive disorder, males tend to develop more symptoms and more severe symptoms than females.
Toshinori Yuasa +10 more
openaire +2 more sources
Drugs of Today, 2006
Fabry disease is an inherited enzyme deficiency of galactosidase A that results in various phenotypes: classic, cardiac or renal. It can present variably and may represent an important cause of occult neurological and cardiac syndromes and renal failure.
openaire +3 more sources
Fabry disease is an inherited enzyme deficiency of galactosidase A that results in various phenotypes: classic, cardiac or renal. It can present variably and may represent an important cause of occult neurological and cardiac syndromes and renal failure.
openaire +3 more sources
Journal of Inherited Metabolic Disease, 2020
The identification of pathogenic GLA variants plays a central role in the establishment of a definite Fabry disease (FD) diagnosis. We aimed to review and interpret the published data on the p.Asp313Tyr (p.D313Y) variant pathogenicity and clinical ...
G. Effraimidis +4 more
semanticscholar +1 more source
The identification of pathogenic GLA variants plays a central role in the establishment of a definite Fabry disease (FD) diagnosis. We aimed to review and interpret the published data on the p.Asp313Tyr (p.D313Y) variant pathogenicity and clinical ...
G. Effraimidis +4 more
semanticscholar +1 more source
The arthropathy of fabry disease [PDF]
Arthritis & Rheumatism, 1979 AbstractFabry disease, an X‐linked recessively inherited glycosphingolipidosis, results from defective activity of the lysosomal enzyme ceramide trihexosidase termed α‐galactosidase A (1). The cumulative deposition of the substrate ceramide trihexose (CTH) in various tissues accounts for the clinical manifestations of the disease (2).
Kumudchandra J. Sheth +2 more
openaire +2 more sources
Joint Bone Spine, 2004
Fabry disease is an inherited deficiency of the lysosomal hydrolase alpha-galactosidase A (alpha GalA) due to mutations in the Gal gene at Xq22. The result is intralysosomal accumulation of glycosphingolipids. In males who carry the mutation (1/40,000), severe multisystem disease develops in childhood or adolescence. Attacks of acute pain lasting a few
Idrissa Cissé +4 more
openaire +3 more sources
Fabry disease is an inherited deficiency of the lysosomal hydrolase alpha-galactosidase A (alpha GalA) due to mutations in the Gal gene at Xq22. The result is intralysosomal accumulation of glycosphingolipids. In males who carry the mutation (1/40,000), severe multisystem disease develops in childhood or adolescence. Attacks of acute pain lasting a few
Idrissa Cissé +4 more
openaire +3 more sources